Cargando…

Preventive Therapy for Contacts of Drug-Resistant Tuberculosis

Preventing the progression of a drug-resistant tuberculosis (DR-TB) infection to disease is an important pillar of the DR-TB elimination strategy. International guidelines have recently proposed fluoroquinolones for tuberculosis preventive therapy (TPT) in DR-TB contacts, although the available evid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kherabi, Yousra, Tunesi, Simone, Kay, Alexander, Guglielmetti, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609446/ https://www.ncbi.nlm.nih.gov/pubmed/36297246 http://dx.doi.org/10.3390/pathogens11101189

Ejemplares similares

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
por: Kherabi, Yousra, et al.
Publicado: (2022)

Landscape of TB Infection and Prevention among People Living with HIV
por: Vasiliu, Anca, et al.
Publicado: (2022)

Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas
por: Pilmis, Benoît, et al.
Publicado: (2023)

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
por: Kherabi, Yousra, et al.
Publicado: (2022)

Optimal management of drug-resistant tuberculosis: Can India lead the way?
por: Masini, Tiziana, et al.
Publicado: (2023)

Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients
por: Salazar-Austin, Nicole, et al.
Publicado: (2022)

Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-Analysis
por: Bodard, Sylvain, et al.
Publicado: (2023)

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
por: Demers, Anne-Marie, et al.
Publicado: (2021)

Community-based tuberculosis contact management: Caregiver experience and factors promoting adherence to preventive therapy
por: Sandoval, Micaela, et al.
Publicado: (2023)

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
por: Fiolet, Thibault, et al.
Publicado: (2022)

Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?
por: Schluger, Neil W.
Publicado: (2020)

COVID-19 : les thérapeutiques
por: KHERABI, Yousra, et al.
Publicado: (2022)

Re: ‘clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection’ by Mailhe et al.
por: Kherabi, Yousra, et al.
Publicado: (2023)

Scaling up tuberculosis preventive therapy for contacts in high transmission settings
por: Majumdar, Suman S, et al.
Publicado: (2020)

Submillisievert Computed Tomography of the Chest in Contact Investigation for Drug-Resistant Tuberculosis
por: Lee, Seung Chul, et al.
Publicado: (2017)

Pediatric Drug-Resistant Tuberculosis: The Current and Future Prospects for Management and Prevention
por: Dharmapalan, Dhanya, et al.
Publicado: (2023)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Vaccins COVID-19 : une course contre la montre
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing?
por: Kadyrov, Meder, et al.
Publicado: (2023)

Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ?
por: Kherabi, Yousra, et al.
Publicado: (2022)

COVID-19 vaccine boosters: What do we know so far?
por: Kherabi, Yousra, et al.
Publicado: (2021)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan
por: Malik, Amyn A., et al.
Publicado: (2021)

Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy
por: Ausi, Yudisia, et al.
Publicado: (2021)

Drug-resistant Spinal Tuberculosis
por: Jain, Anil K, et al.
Publicado: (2018)

Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
por: Johnston, James, et al.
Publicado: (2012)

Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis
por: Rabaan, Ali A., et al.
Publicado: (2022)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu, Meghna, et al.
Publicado: (2011)

Extensively drug-resistant tuberculosis: epidemiology and management
por: Matteelli, Alberto, et al.
Publicado: (2014)

The role of delamanid in the treatment of drug-resistant tuberculosis
por: Lewis, Joseph M, et al.
Publicado: (2015)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Technological tools and strategies for culturing human gut microbiota in engineered in vitro models
por: Sardelli, Lorenzo, et al.
Publicado: (2021)

Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan
por: Sayedi, Said Mirza, et al.
Publicado: (2020)

Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
por: Torfs, Eveline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0mdjdn42mo8gvnhgnb27aid3dn